Ion Beam Applications SA - Company Profile
Powered by 
All the sales intelligence you need on Ion Beam Applications SA in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Ion Beam Applications SA fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Ion Beam Applications SA.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Ion Beam Applications SA (IBA) develops solutions for the diagnosis and treatment of cancer and other serious illnesses. It also offers products for industrial uses such as the sterilization of medical devices. The company offers monitoring equipment and software that enables hospitals to perform calibration procedures during radiation therapy and radiology. The medical technology company focuses its activities on proton therapy solutions, dosimetry, and other accelerators. Its products and services find application in the treatment of cancer, and neurologic and cardiac disorders. It also provides sterilization and ionization solutions for industrial uses. The company has an operational presence across the US, Europe, and Asia. IBA is headquartered in Louvain-la-Neuve, Belgium.
Headquarters
Belgium
Address
3, Chemin du Cyclotron, Louvain-La-Neuve, 1348
Website
www.iba-worldwide.com
Telephone
32 10 475811
No of Employees
2,118
Industry
Medical Equipment
Ticker Symbol & Exchange
IBAB (EBR)
Revenue (2024)
$539.0M
6.7%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
201.6%
(2024 vs 2023)
Market Cap*
$584.5M
Net Profit Margin (2024)
XYZ
195.4%
(2024 vs 2023)
* As of and is in US$
Ion Beam Applications SA premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Proton Therapy: | Project Management | Rhodotron |
| Proteus One | Education and Training | Halcyon |
| Dosimetry: | Support Services | Proteus |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In January, the company entered into an agreement with MacKay Memorial Hospital to supply and install a Proteus ONE compact proton therapy system in New Taipei City, Taiwan. |
| 2025 | Contracts/Agreements | In December, the company entered into an agreement with YAS Healthcare, to supply and install a Proteus ONE compact proton therapy system in Dubai. |
| 2025 | Contracts/Agreements | In December, the company entered into an agreement with the Catholic University of Korea’s Seoul St. Mary’s Hospital to supply a three-room Proteus PLUS proton therapy system in Seoul. |
Competitor Comparison
| Key Parameters | Ion Beam Applications SA | Siemens Healthineers AG | Varian Medical Systems Inc | Acoustic MedSystems Inc | Hitachi Medical Systems (Beijing) Corporation |
|---|---|---|---|---|---|
| Headquarters | Belgium | Germany | United States of America | United States of America | China |
| City | Louvain-La-Neuve | Forchheim | Palo Alto | Savoy | Beijing |
| State/Province | - | Bayern | California | Illinois | Beijing |
| No. of Employees | 2,118 | 72,000 | 10,000 | - | - |
| Entity Type | Public | Public | Private | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Pierre Mottet | Chairman | Executive Board | 2013 | - |
| Olivier Legrain | Managing Director; Chief Executive Officer | Executive Board | 2012 | - |
| Yves Jongen | Chief Research Officer; Director | Executive Board | - | - |
| Catherine Vandenborre | Chief Financial Officer | Senior Management | 2025 | - |
| Henri de Romree | Director; Deputy Chief Executive Officer; Managing Director | Executive Board | 2024 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer